Pierce, Katherine
Pierce, Katherine was paid $98K by Medicaid between Jan 2024 and Dec 2024, across 11 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 37% of everything it billed.
33Billing provider infoPIERCE, KATHERINE
JOHNSTON, RI 02919
JOHNSTON, RI 02919
33aNPI1235470394assigned 03/13/2013
33bProvider typeRegistered Nurse
28Total paid$98K
24GClaims1,038
24DCodes billed11
24AFirst – last monthJan 2024 – Dec 2024
Compared with peers
Next to other Registered Nurse providers in Rhode Island
Rank by total paid#23 of 76
Median peer was paid$29K
This provider vs. median3.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2024incomplete | 1,038 | $98K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 37% | 362 | 350 | $36K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 20% | 133 | 130 | $19K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 16% | 181 | 173 | $16K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 12% | 50 | 44 | $12K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 4.2% | 18 | 18 | $4K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.2% | 39 | 39 | $3K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3.0% | 115 | 112 | $3K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 2.3% | 44 | 44 | $2K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.8% | 44 | 41 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 39 | 39 | $603.41 |
| 81002 | <1% | 13 | 13 | $69.02 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.